Literature DB >> 25404742

Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.

Shen Shen1, Garrett E Berry2, Ruth M Castellanos Rivera1, Roland Y Cheung1, Andrew N Troupes1, Sarah M Brown1, Tal Kafri1, Aravind Asokan3.   

Abstract

Adeno-associated viruses (AAVs) display a highly conserved NGR motif on the capsid surface. Earlier studies have established this tripeptide motif as being essential for integrin-mediated uptake of recombinant AAV serotype 2 (AAV2) in cultured cells. However, functional attributes of this putative integrin recognition motif in other recombinant AAV serotypes displaying systemic transduction in vivo remain unknown. In this study, we dissect the biology of an integrin domain capsid mutant derived from the human isolate AAV9 in mice. The AAV9/NGA mutant shows decreased systemic transduction in mice. This defective phenotype was accompanied by rapid clearance of mutant virions from the blood circulation and nonspecific sequestration by the spleen. Transient vascular hyperpermeability, induced by histamine coinjection, exacerbated AAV9/NGA uptake by the spleen but not the liver. However, such treatment did not affect AAV9 virions, suggesting a potential entry/post-entry defect for the mutant in different tissues. Further characterization revealed modestly decreased cell surface binding but a more pronounced defect in the cellular entry of mutant virions. These findings were corroborated by the observation that blocking multiple integrins adversely affected recombinant AAV9 transduction in different cell types, albeit with variable efficiencies. From a structural perspective, we observed that the integrin recognition motif is located in close proximity to the galactose binding footprint on AAV9 capsids and postulate that this feature could influence cell surface attachment, cellular uptake at the tissue level, and systemic clearance by the reticuloendothelial system.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Adeno-Associated Virus; Cell Surface Receptor; Gene Therapy; Integrin; Viral Protein; Virus Entry

Mesh:

Substances:

Year:  2014        PMID: 25404742      PMCID: PMC4340397          DOI: 10.1074/jbc.M114.608281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Authors:  Qing Xie; Weishu Bu; Smita Bhatia; Joan Hare; Thayumanasamy Somasundaram; Arezki Azzi; Michael S Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

2.  Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.

Authors:  Clare E Thomas; Theresa A Storm; Zan Huang; Mark A Kay
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10.

Authors:  Bin Yang; Shaoyong Li; Hongyan Wang; Yansu Guo; Dominic J Gessler; Chunyan Cao; Qin Su; Joshua Kramer; Li Zhong; Seemin Seher Ahmed; Hongwei Zhang; Ran He; Ronald C Desrosiers; Robert Brown; Zuoshang Xu; Guangping Gao
Journal:  Mol Ther       Date:  2014-04-30       Impact factor: 11.454

4.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

Authors:  K Qing; C Mah; J Hansen; S Zhou; V Dwarki; A Srivastava
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

6.  Identification of PDGFR as a receptor for AAV-5 transduction.

Authors:  Giovanni Di Pasquale; Beverly L Davidson; Colleen S Stein; Inês Martins; Dominic Scudiero; Anne Monks; John A Chiorini
Journal:  Nat Med       Date:  2003-09-14       Impact factor: 53.440

7.  Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency.

Authors:  Shen Shen; Eric D Horowitz; Andrew N Troupes; Sarah M Brown; Nagesh Pulicherla; Richard J Samulski; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

8.  Clades of Adeno-associated viruses are widely disseminated in human tissues.

Authors:  Guangping Gao; Luk H Vandenberghe; Mauricio R Alvira; You Lu; Roberto Calcedo; Xiangyang Zhou; James M Wilson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update.

Authors:  Esther E Schmidt; Oliver Pelz; Svetlana Buhlmann; Grainne Kerr; Thomas Horn; Michael Boutros
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

10.  Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing.

Authors:  Kei Adachi; Tatsuji Enoki; Yasuhiro Kawano; Michael Veraz; Hiroyuki Nakai
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more
  10 in total

1.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

Review 2.  In vivo tissue-tropism of adeno-associated viral vectors.

Authors:  Arun Srivastava
Journal:  Curr Opin Virol       Date:  2016-09-03       Impact factor: 7.090

3.  Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.

Authors:  Lauren M Drouin; Bridget Lins; Maria Janssen; Antonette Bennett; Paul Chipman; Robert McKenna; Weijun Chen; Nicholas Muzyczka; Giovanni Cardone; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

4.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

5.  Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.

Authors:  Sourav R Choudhury; Anne F Harris; Damien J Cabral; Allison M Keeler; Ellen Sapp; Jennifer S Ferreira; Heather L Gray-Edwards; Jacob A Johnson; Aime K Johnson; Qin Su; Lorelei Stoica; Marian DiFiglia; Neil Aronin; Douglas R Martin; Guangping Gao; Miguel Sena-Esteves
Journal:  Mol Ther       Date:  2015-12-28       Impact factor: 11.454

6.  Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno-Associated Viral Vector rAAV9P1.

Authors:  Amelie Bauer; Matteo Puglisi; Dennis Nagl; Joel A Schick; Thomas Werner; Andreas Klingl; Jihad El Andari; Veit Hornung; Horst Kessler; Magdalena Götz; Dirk Grimm; Ruth Brack-Werner
Journal:  Adv Sci (Weinh)       Date:  2022-04-10       Impact factor: 17.521

Review 7.  Adeno-associated virus (AAV)-based gene therapy for glioblastoma.

Authors:  Xin Xu; Wenli Chen; Wenjun Zhu; Jing Chen; Bin Ma; Jianxia Ding; Zaichuan Wang; Yifei Li; Yeming Wang; Xiaochun Zhang
Journal:  Cancer Cell Int       Date:  2021-01-26       Impact factor: 5.722

8.  Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome.

Authors:  Jayanth S Chandran; Paul S Sharp; Evangelia Karyka; João Miguel da Conceição Aves-Cruzeiro; Ian Coldicott; Lydia Castelli; Guillaume Hautbergue; Mark O Collins; Mimoun Azzouz
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

9.  A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates.

Authors:  Dan Wang; Shaoyong Li; Dominic J Gessler; Jun Xie; Li Zhong; Jia Li; Karen Tran; Kim Van Vliet; Lingzhi Ren; Qin Su; Ran He; Jason E Goetzmann; Terence R Flotte; Mavis Agbandje-McKenna; Guangping Gao
Journal:  Mol Ther Methods Clin Dev       Date:  2018-03-16       Impact factor: 6.698

10.  Receptor Switching in Newly Evolved Adeno-associated Viruses.

Authors:  L Patrick Havlik; Anshuman Das; Mario Mietzsch; Daniel K Oh; Jonathan Ark; Robert McKenna; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.